Lantheus Holdings (LNTH) Liabilities from Discontinued Operations (2015 - 2025)
Lantheus Holdings (LNTH) reported Liabilities from Discontinued Operations of 22468000.0 for Q4 2025, down 21.35% quarter-over-quarter from 28566000.0 in Q3 2025.
Lantheus Holdings (LNTH) Liabilities from Discontinued Operations (2015 - 2025) Analysis & Trends
Lantheus Holdings (LNTH) has 3 years of Liabilities from Discontinued Operations data on file, last reported at 22468000.0 in Q4 2025.
- Liabilities from Discontinued Operations for Q4 2025 came in at 22468000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 22468000.0 (changed N/A YoY), and the FY2025 annual result was 22468000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations retreated to 22468000.0 in Q4 2025 per LNTH's latest filing, from 28566000.0 in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at 29845000.0 in Q2 2025 and troughed at 22468000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Hims & Hers Health | 6.15 Bn | 5.40 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.47 Mn |
| Dec 31, 2025 | 22.47 Mn |
| Sep 30, 2025 | 28.57 Mn |
| Sep 30, 2025 | 28.57 Mn |
| Jun 30, 2025 | 29.85 Mn |
| Jun 30, 2025 | 29.85 Mn |
| Dec 31, 2020 | 1.79 Mn |
| Dec 31, 2020 | 1.79 Mn |
| Dec 31, 2015 | 1.72 Mn |
| Dec 31, 2015 | 1.72 Mn |